
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.770 | 2.860 | 0.090 |
Shares | 97.230 | 97.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.515 | 18.164 |
Price to Book | 3.976 | 3.695 |
Price to Sales | 5.414 | 5.353 |
Price to Cash Flow | 12.916 | 13.633 |
Dividend Yield | 0.576 | 0.516 |
5 Years Earnings Growth | 9.245 | 19.708 |
Number of long holdings: 83
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 6.34 | 110.03 | +2.21% | |
Amgen | US0311621009 | 5.32 | 297.93 | +1.24% | |
Regeneron Pharma | US75886F1075 | 5.09 | 696.02 | +1.51% | |
Vertex | US92532F1003 | 4.87 | 480.33 | +1.82% | |
Alnylam | US02043Q1076 | 4.37 | 251.00 | +0.20% | |
BioNTech | US09075V1026 | 3.59 | 117.88 | -1.42% | |
Argen-X | NL0010832176 | 2.72 | 617.00 | +0.19% | |
Ascendis Pharma AS | US04351P1012 | 2.57 | 154.58 | -0.34% | |
Neurocrine | US64125C1099 | 2.50 | 116.11 | +1.62% | |
Insmed | US4576693075 | 2.28 | 83.61 | -0.26% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 3.2B | 2.86 | 10.90 | - | ||
Cleome Index USA Equities Z USD Acc | 3.2B | 24.19 | 7.88 | 12.43 | ||
Cleome Index USA Eq C USD Inc | 3.08B | 23.07 | 6.85 | - | ||
Cleome Index USA Eq C USD Acc | 3.08B | 23.07 | 6.84 | 11.23 | ||
LU1864481467 | 1.58B | -2.39 | -4.36 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review